4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-23-048483
Options or other derivatives
- President acquired 545,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Ryan Charles S. President | 2023-09-01 | Grant or award · Employee Stock Option (right to buy) | +545,000 | 545,000 | D: show line 1 in the form |
Loading xslF345X05/doc4.xml…